The Latest

  • The words "accelerating growth" appear in white text on a blue background of flowing, wave-like designs, accompanied by the Informa TechTarget logo and company name.
    Image attribution tooltip

    Informa TechTarget

    Image attribution tooltip

    Note from the Editor-in-Chief

    A change in ownership and what it means for our readers.

  • Businessman analytics Ai technology digital transformation change management, internet of things.
    Image attribution tooltip
    Sittipol Sukuna via Getty Images
    Image attribution tooltip
    Sponsored by IFS

    The power of composability: Overcoming field service management challenges in MedTech

    Composable software seamlessly integrates with core systems, facilitating communication and real-time data sharing between diverse systems.

  • A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
    Image attribution tooltip
    aprott via Getty Images
    Image attribution tooltip

    Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs

    About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.

  • The exterior of the Veterans Affairs Hospital in New York City.
    Image attribution tooltip
    Spencer Platt/Getty Images via Getty Images
    Image attribution tooltip

    Medtronic wins VA contract to install AI-powered endoscopy units

    The three-year contract expands Medtronic’s work with the VA to cover the installation of almost 100 more GI Genius endoscopy modules at U.S. centers.

  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta discontinues insulin patch pump development

    CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.”

  • Xray of a man's knee
    Image attribution tooltip
    gorodenkoff via Getty Images
    Image attribution tooltip

    Zimmer wins FDA approval for cementless partial knee implant

    The device is established in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.

  • Donald Trump speaks at a campaign event in Reading, Pennsylvania.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip

    Trump calls for 25% tariffs on imports from Canada and Mexico

    The president-elect also called for additional 10% tariffs on imports from China as part of his day one White House plans.

    Updated Nov. 26, 2024
  • A person wearing gloves holds a round, metallic device in their palms.
    Image attribution tooltip
    Courtesy of Intera Oncology
    Image attribution tooltip

    Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

    Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.

  • A person in a dark suit speaks on stage during a film screening.
    Image attribution tooltip
    Noam Galai via Getty Images
    Image attribution tooltip

    Johns Hopkins surgeon Makary is Trump’s pick to lead FDA

    A prolific medical researcher and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

    FDA
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic, Tempus testing AI to find potential TAVR patients

    The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not have a treatment plan in place.

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic buys surgical instrument developer Fortimedix

    Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.

  • Front sign of FDA building
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA plan would alert public sooner on high-risk device recalls

    The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of potentially high-risk recalls and when the public is notified.

  • A white, rectangular sticker device is in front of a blue, pen-shaped device.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic nets FDA nod for smart insulin pen app

    The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.

  • RFK Jr. shakes hands with Donald trump on stage with a crowd behind watching
    Image attribution tooltip
    Rebecca Noble via Getty Images
    Image attribution tooltip

    Healthcare industry braces for RFK Jr.

    Kennedy's views on vaccines in particular are causing alarm among some physicians and investors.

  • A brick building with a sign that says "Henry Schein Inc."
    Image attribution tooltip
    Bruce Bennett via Getty Images
    Image attribution tooltip

    Henry Schein to acquire medical supplier Acentus

    Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.

    M&A
  • Professional photo of Vicky Demas
    Image attribution tooltip
    Courtesy of Identifeye Health
    Image attribution tooltip

    Verily alum looks to improve access to retinal scans

    CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.

  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips revises ventilator directions after airflow issue tied to 4 injuries

    Aerosol deposits could accumulate on a sensor and affect oxygen delivery, the FDA said in a recall notice. Several of the ventilator models were previously recalled for separate problems.

  • President-elect Donald Trump, wearing a MAGA hat, and Dr. Oz shake hands as Oz exits a stage.
    Image attribution tooltip
    Win McNamee / Staff via Getty Images
    Image attribution tooltip

    Advamed CEO welcomes Dr. Oz as Trump’s pick to lead CMS

    Scott Whitaker said Mehmet Oz knows firsthand the impact of medical technologies on disease prevention and treatment. Oz holds a patent on Abbott’s Mitraclip heart device.

  • A picture of five Ōura smart rings against a gold background.
    Image attribution tooltip
    Courtesy of Ōura
    Image attribution tooltip

    Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs

    The partnership will support data flows that enable people who use both companies’ devices to track how glucose levels affect other health metrics.

  • A headshot of Julia Wang, Labcorp's incoming CFO.
    Image attribution tooltip
    Permission granted by Labcorp
    Image attribution tooltip

    Labcorp hires Julia Wang as CFO

    Wang will replace Glenn Eisenberg, who is retiring after 10 years in the role. Evercore analysts called Eisenberg a Labcorp “institution.”

  • Dr. Oz waves to campaign supporters
    Image attribution tooltip
    Win McNamee/Getty Images via Getty Images
    Image attribution tooltip

    Trump nominates Dr. Oz to oversee Medicare, Medicaid as CMS head

    On Truth Social, President-elect Donald Trump said Oz, who is best known for his eponymous TV show, would take on the “illness industrial complex.” 

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s ablation sales slowed by PFA supply issues

    CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.

  • A picture of building with large glass windows and a parking lot, with flowers and grass in the foreground
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott opens plant in Ireland to boost Libre 3 sensor production

    More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    The PFA race is heating up. Here’s where the market stands after J&J’s approval.

    Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space as new devices and heart imaging technology hit the market.

  • A closeup of Boston Scientific's Watchman FLX device is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific’s Watchman could be new option for patients post ablation: study

    The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent cardiac ablation for AFib.

  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    FDA warns providers on Getinge devices tied to 17 serious injuries

    Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.